Abstract
Despite recent initiatives, the UK is failing adequately to address the inequities in healthcare provision for children with rare lung disease Money drives research—whether it is for profit by drug...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
